Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eeles

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|February 18, 2011
Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS StudyJ Hutton, L G Walker, F J Gilbert, et al.
Public Health Genomics|February 1, 2013
Stratified cancer screening: the practicalities of implementationT Dent, J Jbilou, I Rafi, et al.
Journal of Medical Genetics|February 24, 2001
Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. The CRC/BPG UK Familial Prostate Cancer Study Coordinators and Collaborators. The EU Biomed CollaboratorsM Badzioch, R Eeles, G Leblanc, et al.
Prostate Cancer and Prostatic Diseases|September 3, 2008
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillanceS Jhavar, J Bartlett, G Kovacs, et al.
Clinical and Experimental Immunology|March 25, 2014
Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancerN E Annels, G R Simpson, M Denyer, et al.
Genetic Testing|May 14, 2004
Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohortC Foster, D G R Evans, R Eeles, et al.
Oncology Reports|January 1, 2010
Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriersA V Mitra, C Jameson, Y Barbachano, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancerZ Kote-Jarai, F Durocher, S M Edwards, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriersE Castro, S Jugurnauth-Little, Q Karlsson, et al.
Pharmacogenetics|July 4, 2001
Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancerZ Kote-Jarai, D Easton, S M Edwards, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|February 18, 2011
Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS StudyJ Hutton, L G Walker, F J Gilbert, et al.
Public Health Genomics|February 1, 2013
Stratified cancer screening: the practicalities of implementationT Dent, J Jbilou, I Rafi, et al.
Journal of Medical Genetics|February 24, 2001
Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. The CRC/BPG UK Familial Prostate Cancer Study Coordinators and Collaborators. The EU Biomed CollaboratorsM Badzioch, R Eeles, G Leblanc, et al.
Prostate Cancer and Prostatic Diseases|September 3, 2008
Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillanceS Jhavar, J Bartlett, G Kovacs, et al.
Clinical and Experimental Immunology|March 25, 2014
Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancerN E Annels, G R Simpson, M Denyer, et al.
Genetic Testing|May 14, 2004
Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohortC Foster, D G R Evans, R Eeles, et al.
Oncology Reports|January 1, 2010
Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriersA V Mitra, C Jameson, Y Barbachano, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancerZ Kote-Jarai, F Durocher, S M Edwards, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriersE Castro, S Jugurnauth-Little, Q Karlsson, et al.
Pharmacogenetics|July 4, 2001
Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancerZ Kote-Jarai, D Easton, S M Edwards, et al.
Pageof 11